OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) CEO Aaron Green bought 36,920 shares of OneMedNet stock in a transaction on Friday, June 12th. The stock was purchased at an average price of $0.56 per share, with a total value of $20,675.20. Following the completion of the acquisition, the chief executive officer directly owned 1,841,023 shares of the company’s stock, valued at $1,030,972.88. This represents a 2.05% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Aaron Green also recently made the following trade(s):
- On Monday, June 15th, Aaron Green purchased 18,702 shares of OneMedNet stock. The shares were purchased at an average cost of $0.54 per share, with a total value of $10,099.08.
OneMedNet Stock Performance
NASDAQ:ONMD opened at $0.56 on Friday. OneMedNet Corporation has a fifty-two week low of $0.34 and a fifty-two week high of $4.22. The stock has a market capitalization of $30.44 million, a P/E ratio of -11.18 and a beta of 1.12. The company’s 50-day simple moving average is $0.84 and its 200-day simple moving average is $0.94.
Institutional Investors Weigh In On OneMedNet
A number of large investors have recently modified their holdings of ONMD. Virtu Financial LLC purchased a new position in shares of OneMedNet in the 4th quarter valued at approximately $48,000. State Street Corp boosted its stake in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after purchasing an additional 34,200 shares in the last quarter. Jane Street Group LLC purchased a new stake in OneMedNet during the 4th quarter worth approximately $119,000. HRT Financial LP purchased a new stake in OneMedNet during the 4th quarter worth approximately $32,000. Finally, Exencial Wealth Advisors LLC grew its position in OneMedNet by 1.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock worth $4,009,000 after purchasing an additional 45,401 shares during the last quarter. Hedge funds and other institutional investors own 0.95% of the company’s stock.
Analysts Set New Price Targets
Several research firms have issued reports on ONMD. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OneMedNet in a report on Monday, June 1st. Wall Street Zen lowered OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.
View Our Latest Analysis on ONMD
OneMedNet Company Profile
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Featured Stories
- Five stocks we like better than OneMedNet
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
